Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ASCO 2024: Latest Data in Melanoma : Episode 4
ASCO 2024 Highlights: Long-Term Data and the Future of Combination Therapies in Melanoma
Dr Lipson provides insights surrounding combination therapies in melanoma management.
EP: 1.ASCO 2024: Addressing Unmet Needs in Melanoma Treatment and Management
EP: 2.Key Findings from the NADINA Trial at ASCO 2024
EP: 3.ASCO 2024: Impact of RELATIVITY-047 on Metastatic Melanoma Management
Now Viewing
EP: 4.ASCO 2024 Highlights: Long-Term Data and the Future of Combination Therapies in Melanoma
EP: 5.Highlights from ASCO 2024: Individualized Neoantigen Therapy in Melanoma
EP: 6.ASCO 2024: Emerging Data on Brenetafusp (IMC-F106C) ImmTAC Bispecific in Melanoma
EP: 7.Melanoma Research Beyond ASCO 2024: Upcoming Advances and Insights
Video content above is prompted by the following:
- What is the value of long-term follow-up data in melanoma? How does this impact use of treatment regimens?
- How do you foresee the role of combination therapies evolving in the treatment of melanoma over the next few years?
Related Videos
Related Content
ICYMI: Highlights From AMCP Nexus 2024
December 26th 2024Article
Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.
Read More
